中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

microRNA-122在肝病发生发展及诊断中的作用

陈泽山 文彬 丘佩容 蓝红妮 黄宝特 邓鑫

陈泽山, 文彬, 丘佩容, 等. microRNA-122在肝病发生发展及诊断中的作用[J]. 临床肝胆病杂志, 2021, 37(7): 1724-1728. DOI: 10.3969/j.issn.1001-5256.2021.07.052
引用本文: 陈泽山, 文彬, 丘佩容, 等. microRNA-122在肝病发生发展及诊断中的作用[J]. 临床肝胆病杂志, 2021, 37(7): 1724-1728. DOI: 10.3969/j.issn.1001-5256.2021.07.052
CHEN ZS, WEN B, QIU PR, et al. Role of microRNA- 122 in the development, progression, and diagnosis of liver disease[J]. J Clin Hepatol, 2021, 37(7): 1724-1728. DOI: 10.3969/j.issn.1001-5256.2021.07.052
Citation: CHEN ZS, WEN B, QIU PR, et al. Role of microRNA- 122 in the development, progression, and diagnosis of liver disease[J]. J Clin Hepatol, 2021, 37(7): 1724-1728. DOI: 10.3969/j.issn.1001-5256.2021.07.052

microRNA-122在肝病发生发展及诊断中的作用

DOI: 10.3969/j.issn.1001-5256.2021.07.052
基金项目: 

国家自然科学基金 81860790

广西自然科学基金项目 2017GXNSFAA198183

详细信息
    通讯作者:

    邓鑫, dx8849@163.com

  • 中图分类号: R575

Role of microRNA-122 in the development, progression, and diagnosis of liver disease

Funds: 

National Natural Science Foundation of China 81860790

Guangxi Natural Science Foundation of China 2017GXNSFAA198183

  • 摘要: microRNA(miRNA)是一类小分子非编码RNA, 转录后通过调控基因表达参与细胞增殖和凋亡等多个环节。目前越来越多的证据表明miRNA-122参与了多种肝病的发生、发展, 通过查阅相关文献报道, 总结了miRNA-122在非酒精性脂肪性肝病、肝炎、肝纤维化、肝癌等多种肝病中作用的研究进展, 同时分析了miRNA-122作为一种新型无创的生物学标志物的潜能, 为探索肝脏疾病诊疗提供参考。

     

  • [1] MATSUYAMA H, SUZUKI HI. Systems and synthetic microRNA biology: From biogenesis to disease pathogenesis[J]. Int J Mol Sci, 2019, 21(1): 132. DOI: 10.3390/ijms21010132.
    [2] ZHAO Y, WANG Z, ZHANG W, et al. MicroRNAs play an essential role in autophagy regulation in various disease phenotypes[J]. Biofactors, 2019, 45(6): 844-856. DOI: 10.1002/biof.1555.
    [3] LEE RC, FEINBAUM RL, AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5): 843-854. DOI: 10.1016/0092-8674(93)90529-y.
    [4] FIRE A, XU S, MONTGOMERY MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391(6669): 806-811. DOI: 10.1038/35888.
    [5] LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, et al. Identification of novel genes coding for small expressed RNAs[J]. Science, 2001, 294(5543): 853-858. DOI: 10.1126/science.1064921.
    [6] KOZOMARA A, GRIFFITHS-JONES S. miRBase: Annotating high confidence microRNAs using deep sequencing data[J]. Nucleic Acids Res, 2014, 42(Database issue): d68-d73. DOI: 10.1093/nar/gkt1181.
    [7] LAGOS-QUINTANA M, RAUHUT R, YALCIN A, et al. Identification of tissue-specific microRNAs from mouse[J]. Curr Biol, 2002, 12(9): 735-739. DOI: 10.1016/s0960-9822(02)00809-6.
    [8] YOUNOSSI ZM. Non-alcoholic fatty liver disease - A global public health perspective[J]. J Hepatol, 2019, 70(3): 531-544. DOI: 10.1016/j.jhep.2018.10.033.
    [9] YAMADA H, SUZUKI K, ICHINO N, et al. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver[J]. Clin Chim Acta, 2013, 424: 99-103. DOI: 10.1016/j.cca.2013.05.021.
    [10] LONG JK, DAI W, ZHENG YW, et al. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease[J]. Mol Med, 2019, 25(1): 26. DOI: 10.1186/s10020-019-0085-2.
    [11] PURUSHOTHAM A, SCHUG TT, XU Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation[J]. Cell Metab, 2009, 9(4): 327-338. DOI: 10.1016/j.cmet.2009.02.006.
    [12] LI X. SIRT1 and energy metabolism[J]. Acta Biochim Biophys Sin(Shanghai), 2013, 45(1): 51-60. DOI: 10.1093/abbs/gms108.
    [13] WANG S, QIU L, YAN X, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity[J]. Hepatology, 2012, 55(3): 730-741. DOI: 10.1002/hep.24809.
    [14] QU JH, ZHU MH, LIN J, et al. Effects of hepatitis B virus on p53 expression in hepatoma cell line SMMU-7721[J]. World J Gastroenterol, 2005, 11(39): 6212-6215. DOI: 10.3748/wjg.v11.i39.6212.
    [15] CHEN Y, SHEN A, RIDER PJ, et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication[J]. FASEB J, 2011, 25(12): 4511-4521. DOI: 10.1096/fj.11-187781.
    [16] XU H, XU SJ, XIE SJ, et al. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway[J]. Elife, 2019, 8. DOI: 10.7554/eLife.41159.
    [17] WACK A, TERCZYŃSKA-DYLA E, HARTMANN R. Guarding the frontiers: The biology of type Ⅲ interferons[J]. Nat Immunol, 2015, 16(8): 802-809. DOI: 10.1038/ni.3212.
    [18] LI XD, SUN L, SETH RB, et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity[J]. Proc Natl Acad Sci U S A, 2005, 102(49): 17717-17722. DOI: 10.1073/pnas.0508531102.
    [19] GERRESHEIM GK, DVNNES N, NIEDER-RÖHRMANN A, et al. microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3' untranslated region: Function in replication and influence of RNA secondary structure[J]. Cell Mol Life Sci, 2017, 74(4): 747-760. DOI: 10.1007/s00018-016-2377-9.
    [20] HE YJ, HUANG ML, LE Y, et al. Effect of myricitrin on replication of hepatitis C virus through microRNA-122[J]. Pharmacol Clin Chin Materia Med, 2020, 36(4): 99-102. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202004019.htm

    何玉娇, 黄茂林, 乐燕, 等. 杨梅苷通过microRNA-122对丙型肝炎病毒复制的影响[J]. 中药药理与临床, 2020, 36(4): 99-102. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202004019.htm
    [21] KATAREY D, VERMA S. Drug-induced liver injury[J]. Clin Med (Lond), 2016, 16(Suppl 6): s104-s109. DOI: 10.7861/clinmedicine.16-6-s104.
    [22] LI LN, LI Y, PENG JY. microRNA and drug-induced liver injury[J]. Chin J Clin Pharmacol Ther, 2020, 25(7): 803-809. DOI: 10.12092/j.issn.1009-2501.2020.07.013.

    许丽娜, 李月, 彭金咏. microRNA与药物性肝损伤[J]. 中国临床药理学与治疗学, 2020, 25(7): 803-809. DOI: 10.12092/j.issn.1009-2501.2020.07.013.
    [23] CHOWDHARY V, TENG KY, THAKRAL S, et al. miRNA-122 protects mice and human hepatocytes from acetaminophen toxicity by regulating cytochrome P450 family 1 subfamily a member 2 and family 2 subfamily E member 1 expression[J]. Am J Pathol, 2017, 187(12): 2758-2774. DOI: 10.1016/j.ajpath.2017.08.026.
    [24] Liver Disease Committee, Chinese Association of Integrative Medicine. Guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western medicine (2019 edition)[J]. J Clin Hepatol, 2019, 35(7): 1444-1449. DOI: 10.3969/j.issn.1001-5256.2019.07.007.

    中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(7): 1444-1449. DOI: 10.3969/j.issn.1001-5256.2019.07.007.
    [25] YANG AT, HU DD, WANG P, et al. TGF-β1 induces the dual regulation of hepatic progenitor cells with both anti- and proliver fibrosis[J]. Stem Cells Int, 2016, 2016: 1492694. DOI: 10.1155/2016/1492694.
    [26] LI JH, HUANG XR, ZHU HJ, et al. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions[J]. Kidney Int, 2003, 63(6): 2010-2019. DOI: 10.1046/j.1523-1755.2003.00016.x.
    [27] CHENG B, ZHU Q, LIN W, et al. MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway[J]. Exp Ther Med, 2019, 17(1): 284-290. DOI: 10.3892/etm.2018.6962.
    [28] WANG SC, LIN XL, LI J, et al. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA[J]. PLoS One, 2014, 9(7): e101330. DOI: 10.1371/journal.pone.0101330.
    [29] CSAK T, BALA S, LIPPAI D, et al. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis[J]. Liver Int, 2015, 35(2): 532-541. DOI: 10.1111/liv.12633.
    [30] LU SC, AKANJI AO. Leptin, obesity, and hypertension: A review of pathogenetic mechanisms[J]. Metab Syndr Relat Disord, 2020, 18(9): 399-405. DOI: 10.1089/met.2020.0065.
    [31] BENBAIBECHE H, BOUNIHI A, KOCEIR EA. Leptin level as a biomarker of uncontrolled eating in obesity and overweight[J]. Ir J Med Sci, 2021, 190(1): 155-161. DOI: 10.1007/s11845-020-02316-1.
    [32] DUAN DM, JHANG JY, WU S, et al. Modification effect of sex and obesity on the correlation of LEP polymorphisms with leptin levels in Taiwanese obese women[J]. Mol Genet Genomic Med, 2020, 8(3): e1113. DOI: 10.1002/mgg3.1113.
    [33] CAO Q, ZHU X, ZHAI X, et al. Leptin suppresses microRNA-122 promoter activity by phosphorylation of FOXO1 in hepatic stellate cell contributing to leptin promotion of mouse liver fibrosis[J]. Toxicol Appl Pharmacol, 2018, 339: 143-150. DOI: 10.1016/j.taap.2017.12.007.
    [34] MATTIUZZI C, LIPPI G. Current cancer epidemiology[J]. J Epidemiol Glob Health, 2019, 9(4): 217-222. DOI: 10.2991/jegh.k.191008.001.
    [35] SZABO G, BALA S. MicroRNAs in liver disease[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(9): 542-552. DOI: 10.1038/nrgastro.2013.87.
    [36] YAHYA S, FATHY SA, EL-KHAYAT ZA, et al. Possible role of microRNA-122 in modulating multidrug resistance of hepatocellular carcinoma[J]. Indian J Clin Biochem, 2018, 33(1): 21-30. DOI: 10.1007/s12291-017-0651-8.
    [37] BAI S, NASSER MW, WANG B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem, 2009, 284(46): 32015-32027. DOI: 10.1074/jbc.M109.016774.
    [38] YANG G, ZHANG M, ZHAO Y, et al. HNF-4α inhibits hepatocellular carcinoma cell proliferation through miR-122-adam17 pathway[J]. PLoS One, 2020, 15(3): e0230450. DOI: 10.1371/journal.pone.0230450.
    [39] ZHANG S, LIN YH, TARLOW B, et al. The origins and functions of hepatic polyploidy[J]. Cell Cycle, 2019, 18(12): 1302-1315. DOI: 10.1080/15384101.2019.1618123.
    [40] MARGALL-DUCOS G, CELTON-MORIZUR S, COUTON D, et al. Liver tetraploidization is controlled by a new process of incomplete cytokinesis[J]. J Cell Sci, 2007, 120(Pt 20): 3633-3639. DOI: 10.1242/jcs.016907.
    [41] GUIDOTTI JE, BRÉGERIE O, ROBERT A, et al. Liver cell polyploidization: A pivotal role for binuclear hepatocytes[J]. J Biol Chem, 2003, 278(21): 19095-19101. DOI: 10.1074/jbc.M300982200.
    [42] DONNE R, SAROUL-AÏNAMA M, CORDIER P, et al. Polyploidy in liver development, homeostasis and disease[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(7): 391-405. DOI: 10.1038/s41575-020-0284-x.
    [43] ZHANG S, ZHOU K, LUO X, et al. The polyploid state plays a tumor-suppressive role in the liver[J]. Dev Cell, 2018, 47(3): 390. DOI: 10.1016/j.devcel.2018.10.020.
    [44] LIN YH, ZHANG S, ZHU M, et al. Mice with increased numbers of polyploid hepatocytes maintain regenerative capacity but develop fewer hepatocellular carcinomas following chronic liver injury[J]. Gastroenterology, 2020, 158(6): 1698-1712.e14. DOI: 10.1053/j.gastro.2020.01.026.
    [45] HSU SH, DELGADO ER, OTERO PA, et al. MicroRNA-122 regulates polyploidization in the murine liver[J]. Hepatology, 2016, 64(2): 599-615. DOI: 10.1002/hep.28573.
    [46] GUO BH, WU DD, KUANG YL. SF, 25-OH Vit D and miR-122 levels in patients with NAFLD expression and clinical significance[J]. Chin Foreign Med Res, 2020, 18(6): 153-156. DOI: 10.14033/j.cnki.cfmr.2020.06.065.

    郭笔红, 吴丹丹, 邝燕玲. SF、25-OH Vit D及miR-122水平在NAFLD患者中表达及临床意义[J]. 中外医学研究, 2020, 18(6): 153-156. DOI: 10.14033/j.cnki.cfmr.2020.06.065.
    [47] OMRAN AA, OSMAN KS, KAMEL HM, et al. MicroRNA-122 as a novel non-invasive marker of liver fibrosis in hepatitis C virus patients[J]. Clin Lab, 2016, 62(7): 1329-1337. DOI: 10.7754/Clin.Lab.2015.151141.
    [48] WANG K, ZHANG S, MARZOLF B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury[J]. Proc Natl Acad Sci U S A, 2009, 106(11): 4402-4407. DOI: 10.1073/pnas.0813371106.
    [49] MCGILL MR, SHARPE MR, WILLIAMS CD, et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation[J]. J Clin Invest, 2012, 122(4): 1574-1583. DOI: 10.1172/JCI59755.
    [50] ANTOINE DJ, DEAR JW, LEWIS PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital[J]. Hepatology, 2013, 58(2): 777-787. DOI: 10.1002/hep.26294.
    [51] DEAR JW, CLARKE JI, FRANCIS B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: Results from two prospective cohort studies[J]. Lancet Gastroenterol Hepatol, 2018, 3(2): 104-113. DOI: 10.1016/S2468-1253(17)30266-2.
    [52] FRANCK M, SCHÁTTE K, MALFERTHEINER P, et al. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factor[J]. World J Gastroenterol, 2020, 26(1): 86-96. DOI: 10.3748/wjg.v26.i1.86.
    [53] ZHAO XF, LI N, LIN DD, et al. Circulating microRNA-122 for the diagnosis of hepatocellular carcinoma: A meta-analysis[J]. Biomed Res Int, 2020, 2020: 5353695. DOI: 10.1155/2020/5353695.
  • 加载中
计量
  • 文章访问数:  41
  • HTML全文浏览量:  29
  • PDF下载量:  15
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-12-03
  • 修回日期:  2020-12-25
  • 刊出日期:  2021-07-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回